These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6426047)

  • 21. [Auranofin in the treatment of chronic polyarthritis. Results of an open multicenter study].
    Siegmeth W
    Wien Klin Wochenschr Suppl; 1984; 156():27-33. PubMed ID: 6442053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review.
    Horton RJ
    Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Auranofin: experience to date.
    Blodgett RC
    Am J Med; 1983 Dec; 75(6A):86-9. PubMed ID: 6419601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An oral gold formulation in rheumatoid arthritis. A 12-month follow-up report.
    Schorn D
    S Afr Med J; 1982 Aug; 62(10):313-6. PubMed ID: 6810477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of chrysothiotherapy in the treatment of progressive polyarthritis].
    Vojtísek O; Dostál C; Pavelka K
    Fysiatr Revmatol Vestn; 1984 Apr; 62(2):106-12. PubMed ID: 6430770
    [No Abstract]   [Full Text] [Related]  

  • 27. Auranofin versus placebo in the treatment of rheumatoid arthritis.
    Wenger ME; Alexander S; Bland JH; Blechman WJ
    Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
    Wilson AP; Prouse PJ; Gumpel JM
    Ann Rheum Dis; 1984 Jun; 43(3):511-2. PubMed ID: 6430252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gold therapy in patients with systemic lupus erythematosus.
    Weisman MH; Albert D; Mueller MR; Zvaifler NJ; Hesketh SA; Shragg GP
    Am J Med; 1983 Dec; 75(6A):157-64. PubMed ID: 6419600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchiolitis in a rheumatoid arthritis patient receiving auranofin.
    O'Duffy JD; Luthra HS; Unni KK; Hyatt RE
    Arthritis Rheum; 1986 Apr; 29(4):556-9. PubMed ID: 3085683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
    Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
    Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auranofin: more than just oral gold.
    Waller ES
    Clin Pharm; 1984; 3(2):195. PubMed ID: 6426845
    [No Abstract]   [Full Text] [Related]  

  • 33. Auranofin: a new drug for rheumatoid arthritis.
    Abruzzo JL
    Ann Intern Med; 1986 Aug; 105(2):274-6. PubMed ID: 3089090
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of oral and parenteral gold therapy and placebo in the treatment of rheumatoid arthritis.
    Williams HJ; Ward JR
    Scand J Rheumatol Suppl; 1983; 51():92-9. PubMed ID: 6426054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Auranofin (SK + F 39162) induced enterocolitis in rheumatoid arthritis. A case report.
    Jarner D; Nielsen AM
    Scand J Rheumatol; 1983; 12(3):254-6. PubMed ID: 6414080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auranofin in rheumatoid arthritis.
    Champion GD; Bieri D; Browne CD; Day RO; Graham GG; Haavisto TM; Sambrook PN; Vallance JB
    J Rheumatol Suppl; 1982; 8():137-45. PubMed ID: 6813475
    [No Abstract]   [Full Text] [Related]  

  • 38. Auranofin therapy in rheumatoid arthritis.
    Bernhard GC
    J Lab Clin Med; 1982 Aug; 100(2):167-77. PubMed ID: 6808066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of immunological parameters during auranofin treatment in children affected with juvenile chronic arthritis.
    Fantini F; Cottafava F; Martini A; Murelli M; Franchini E; D'Errico R; Panzarasa R
    Int J Clin Pharmacol Res; 1986; 6(1):61-7. PubMed ID: 3082775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
    van Riel PL; Gribnau FW; van de Putte LB
    J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.